Jason Z. Rose, MHSA

Changes in the medication therapy management (MTM) program willl require planning on how to best fund this program in a way that drives medical cost savings.

Medicare Advantage health plans can become more equitable and value driven by addressing common socioeconomic barriers in medication adherence.

Medication adherence is a key part of Medicare Advantage, and its importance to improving Star Ratings necessitate a renewed focus on the measure.

Polypharmacy and medication adherence are common problems among the Medicare patient population, and this article addresses how Medicare Advantage plans can address these challenges and improve patient outcomes.

Mitigating the high cost of prescription drugs is a win-win to address the complex, multipronged problem of getting patients to take their medications as advised.

Medicare Advantage plans must leverage data-driven insights and omnichannel telepharmacy software to guide meaningful interactions with high-risk members and boost Star Ratings performance.

COVID-19 prompted CMS to make major adjustments to the Medicare Advantage (MA) Star Ratings System, resulting in better-than-average performance for nearly all plans. However, these changes were temporary, and MA plans will have to reset their strategies for 2023 and beyond.

The 2022 performance year’s Star Ratings require Medicare Advantage plans to take a more significant role in preventing readmissions.

Medication adherence is crucial for managing chronic diseases, especially in complex, high-risk patients. Compliance packaging is a key tool for managing these populations.

Medicare Advantage plans have a clear opportunity to improve quality by delivering more comprehensive, timely medication reconciliation services to recently discharged members.

There is an urgent need to accelerate vaccination distribution for vulnerable Americans by overcoming problems involving social determinants of health.

Pharmacy-led telehealth strategies will position Special Needs Plans (SNPs) for Star Ratings success during the pandemic and for years to come.

Dual-eligible Special Needs Plans are at highest risk with newest CMS changes.

Implementing a comprehensive social determinants of health program and addressing the root causes of medication nonadherence could mean the difference between a 3- and 4-star rating in Medicare Advantage.